Stingray Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Stingray Therapeutics?

Stingray Therapeutics has 4 investors including THE CATALYTIC IMPACT FOUNDATION (CIF) And Propel(X).

Q: How much funding has Stingray Therapeutics raised to date?

Stingray Therapeutics has raised obfuscated.

Overview

Stingray Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Stingray Therapeutics

CB Rank

75216

Stingray Therapeutics is a biotech company that develops immunotherapies to treat various types of cancer.

Founded

obfuscation

Private

Venture - Series Unknown

Houston, Texas, United States

1-10

stingraytx.com

Biotechnology

Health Care

Therapeutics

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Seed

OBF

obfuscation

Non-equity Assistance

OBF

obfuscation

Key People

Jonathan Northrup: CEO, Co-Founder, and Board Member
Sunil Sharma: Co-Founder
Past Role: Salarius Pharmaceuticals, Founder

Details

Legal Name

Stingray Therapeutics, Inc

Operating Status

Active

Company Type

For Profit

Founders

Jonathan Northrup, Sunil Sharma

About the Company

Stingray Therapeutics is a biotech company that develops immunotherapies to treat various types of cancer. The company was founded in 2018 and is based in Houston, Texas.

Phone Number

713-503-7707

Predictions & Insights

Growth Insight

See this Growth Insight

Stingray Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

ENPP1 Inhibitor

A potent and selective oral inhibitor targeting ENPP1, which is involved in the regulation of the cGAS-STING pathway and is upregulated in metastatic tumors.

Research & Development

Stingray Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Stingray Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Stingray Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Stingray Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Stingray Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Stingray Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Stingray Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Stingray Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Stingray Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Stingray Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Stingray Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
THE CATALYTIC IMPACT FOUNDATION (CIF)	—	Seed Round - Stingray Therapeutics	—
THE CATALYTIC IMPACT FOUNDATION (CIF)	—	Seed Round - Stingray Therapeutics	—
THE CATALYTIC IMPACT FOUNDATION (CIF)	—	Seed Round - Stingray Therapeutics	—
THE CATALYTIC IMPACT FOUNDATION (CIF)	—	Seed Round - Stingray Therapeutics	—
THE CATALYTIC IMPACT FOUNDATION (CIF)	—	Seed Round - Stingray Therapeutics	—